Vortioxetine
2016P001243
Approved small_molecule terminated
Quick answer
Vortioxetine for Depressive Disorder is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Depressive Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated